Response to ‘Comment on “Effect of Direct‐Acting Antivirals on Prognosis in Older Patients With Hepatitis C Virus‐Related Hepatocellular Carcinoma After Curative Therapy: A Retrospective Study by the Red Cross Liver Study Group in Japan”’

Key Points

• This research examines the impact of Direct-Acting Antivirals on the prognosis of older patients with hepatitis C virus-related hepatocellular carcinoma after curative therapy.
• Retrospective analysis conducted by the Red Cross Liver Study Group in Japan.
• Focus on older patients undergoing treatment for hepatocellular carcinoma related to hepatitis C virus.
• Outcomes measured include prognosis post-curative therapy with Direct-Acting Antivirals.
• Direct-Acting Antivirals were associated with improved prognosis for older patients.
• Significant benefits were observed in patients with hepatitis C virus-related hepatocellular carcinoma after treatment.